Milestone Pharmaceuticals Inc. Company Profile
NASDAQ: MISTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 0.762 +7.01%
Milestone Pharmaceuticals at a glance
Milestone Pharmaceuticals Inc. (NASDAQ: MIST) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Montreal, QC, Canada. Milestone Pharmaceuticals is led by Mr. Joseph G. Oliveto M.B.A. and employs about 38 people. The company's shares have traded publicly since 2019.
At a market capitalization of $88.7 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001408443, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Milestone Pharmaceuticals do?
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is also developing etripamil for the indication of atrial fibrillation with rapid ventricular rate (AFib-RVR). It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.
Business description based on the company's public filings.
Company information
- Legal name
- Milestone Pharmaceuticals Inc.
- Ticker
- NASDAQ: MIST
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Joseph G. Oliveto M.B.A.
- Employees
- 38
- Headquarters
- 1111 Dr. Frederik-Philips Boulevard, Montreal, QC, Canada
- Phone
- 514 336 0444
- Website
- milestonepharma.com
- IPO year
- 2019
- Market cap
- $88.66M
- SEC CIK
- 0001408443
- Latest annual report
- 10-K · Mar 20, 2026
Companies similar to Milestone Pharmaceuticals
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CTORCitius Oncology Inc. | 0.835 | -2.45% | $88.31M | vs MIST |
| RLYBRallybio Corporation | 16.99 | +0.35% | $90.26M | vs MIST |
| EQEquillium Inc. | 1.44 | +3.60% | $91.31M | vs MIST |
| TELOTelomir Pharmaceuticals Inc. | 1.15 | +2.68% | $84.66M | vs MIST |
| OKUROnKure Therapeutics Inc. Class A | 2.30 | -2.13% | $93.14M | vs MIST |
| PMNProMIS Neurosciences Inc. | 9.15 | +0.33% | $82.05M | vs MIST |
| ACRVAcrivon Therapeutics Inc. | 1.87 | -0.53% | $80.14M | vs MIST |
| BMEABiomea Fusion Inc. | 1.37 | +3.79% | $99.05M | vs MIST |